SCHEMBL17181737

SCHEMBL17181737

C=CCONc1ccsc1C(=O)OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 1/20 0.51
ALDH1A1 P00352 5/20 0.48
MAPK1 P28482 1/20 0.48
MAPK10 P53779 4/20 0.48
MAPK8 P45983 3/20 0.48
MAPK9 P45984 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
KMT2A Q03164 3/20 0.47
MAPT P10636 2/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47
MEN1 O00255 1/20 0.47
RAB9A P51151 1/20 0.47
KDM4E B2RXH2 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
LMNA P02545 2/20 0.47
POLB P06746 1/20 0.46
CASP3 P42574 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31744531 0.79 SMN1; SMN2 (0.55) HPGDSMN1; SMN2NPC1ALDH1A1MAPK10
SCHEMBL4956852 0.75 NPC1 (0.63) HPGDSMN1; SMN2NPC1ALDH1A1MAPK1
SCHEMBL4749594 0.75 SMN1; SMN2 (0.64) HPGDSMN1; SMN2NPC1ALDH1A1MAPK1
SCHEMBL5483086 0.73 HPGD (0.48) HPGDSMN1; SMN2NPC1ALDH1A1MAPK10
SCHEMBL15846889 0.73 NPC1 (0.65) HPGDSMN1; SMN2NPC1ALDH1A1MAPK1
SCHEMBL3579523 0.73 NPC1 (0.65) HPGDSMN1; SMN2NPC1ALDH1A1MAPK1
SCHEMBL2799189 0.72 NPC1 (0.59) HPGDSMN1; SMN2NPC1ALDH1A1MAPK1
SCHEMBL9410725 0.72 NPC1 (0.59) HPGDSMN1; SMN2NPC1ALDH1A1MAPK1
SCHEMBL538048 0.72 NPC1 (0.63) HPGDSMN1; SMN2NPC1ALDH1A1MAPK1
SCHEMBL8055595 0.70 KMT2A (0.50) HPGDSMN1; SMN2NPC1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935221-B1 QUINOLONE DERIVATIVES CADILA HEALTHCARE LTD (IN) 2018-02-07 EP disclosed
CN-104903295-B Carbostyril derivative 卡迪拉保健有限公司 2017-09-01 CN disclosed
US-9394300-B2 Quinolone derivatives CADILA HEALTHCARE LIMITED (IN) 2016-07-19 US disclosed
US-20150299193-A1 NOVEL QUINOLONE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2015-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299193-A1 NOVEL QUINOLONE DERIVATIVES NQO2, UGT1A1, CYP11B2 HPGD 346/4885SMN1; SMN2 3982/4885NPC1 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.